ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,899Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 2035

$766K Total Retail Price of All Prescriptions

Rank: 112 out of 2035

344 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,001 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 501 358 1 1
AMLODIPINE BESYLATE 480 333 2 6
OMEPRAZOLE 437 310 3 5
HYDROCODONE-ACETAMINOPHEN 398 125 S3 4 2
LISINOPRIL 340 265 5 3
METOPROLOL TARTRATE 299 259 6 8
TRIAMTERENE-HCTZ 220 175 7 35
CLONIDINE HCL 219 123 8 61
CRESTOR 218 214 9 41
FUROSEMIDE 212 125 10 7
METFORMIN HCL 200 155 11 9
ZOLPIDEM TARTRATE 191 140 12 21
LEVOTHYROXINE SODIUM 184 168 13 4
DIOVAN 180 167 14 76
ISOSORBIDE MONONITRATE ER 155 143 15 32
CARVEDILOL 153 117 16 22
LOSARTAN POTASSIUM 148 87 17 15
AMLODIPINE BESYLATE-BENAZEPRIL 146 120 18 88
ATORVASTATIN CALCIUM 146 104 18 13
METHADONE HCL 143 12 S2 20 93
SERTRALINE HCL 139 65 21 23
NEXIUM 137 113 22 51
IBUPROFEN 128 94 23 43
JANUVIA 127 124 24 85
WARFARIN SODIUM 120 107 25 11
PROAIR HFA 117 59 26 31
CLOPIDOGREL 116 105 27 30
PANTOPRAZOLE SODIUM 115 64 28 42
LIDODERM 115 91 28 72
METOPROLOL SUCCINATE 105 102 30 16
FLUTICASONE PROPIONATE 96 39 31 29
SPIRIVA 95 39 32 44
AZITHROMYCIN 95 64 32 39
PLAVIX 94 78 34 49
LOSARTAN-HYDROCHLOROTHIAZIDE 92 46 35 47
GLYBURIDE-METFORMIN HCL 88 60 R 36 139
ADVAIR DISKUS 85 28 37 38
TAMSULOSIN HCL 84 72 38 25
GABAPENTIN 82 33 39 14
PRAVASTATIN SODIUM 82 75 39 17
GLIPIZIDE 81 69 41 54
GLYBURIDE 80 74 R 42 74
ATENOLOL 77 64 43 10
CYCLOBENZAPRINE HCL 76 0 R 44 64
OXYCODONE HCL 76 20 S2 44 62
POTASSIUM CHLORIDE 74 0 46 18
LIPITOR 74 53 46 134
MELOXICAM 73 52 48 56
DIOVAN HCT 71 71 49 126
HYDRALAZINE HCL 68 52 50 45
JANUMET 65 52 51 221
HYDROCHLOROTHIAZIDE 64 50 52 12
KLOR-CON M20 61 45 53 73
LOVAZA 60 48 54 137
MIRTAZAPINE 59 23 55 46
ALENDRONATE SODIUM 59 59 55 27
ACTOS 56 52 57 124
VOLTAREN 54 38 58 141
DONEPEZIL HCL 54 43 58 24
TERAZOSIN HCL 53 39 60 149
CIPROFLOXACIN HCL 53 32 60 63
AMMONIUM LACTATE 52 13 62 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.